// App-Quantinova.ai

133 : Integrated molecular characterization of uterine carcinosarcoma in The Cancer Genome Atlas (TCGA) project

Researchers

Presenter

  • Rehan Akbani

Principal Investigators

  • Douglas A. Levine

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Uterine carcinosarcoma

  • Endometrial Cancer

  • Solid malignancies

Biomarkers

  • Phosphatase and tensin homolog

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • KRAS proto-oncogene, GTPase

  • Solute Carrier Family 22 Member 3

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved